Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Chest

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/chest.13-0076PMID 23788274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.

  2015cited by this paper
• Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy

  2012cited by this paper
• Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment

  2012cited by this paper
• Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort

  2012cited by this paper
• Ventilator-associated pneumonia rates at major trauma centers compared with a national benchmark: A multi-institutional study of the AAST

  2012cited by this paper
• A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia

  2012cited by this paper
• Ventilator-Associated Pneumonia: A Review

  2012cited by this paper
• Short- versus Long-Course Antibacterial Therapy for Community-Acquired Pneumonia

  2012cited by this paper
• Device-associated infection rates in Adult Intensive Care Units in Catalonia: VINCat Program findings.

  2012cited by this paper
• An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients

  2012cited by this paper
• Surveillance on secular trends of incidence and mortality for device–associated infection in the intensive care unit setting at a tertiary medical center in Taiwan, 2000–2008: A retrospective observational study

  2012cited by this paper
• Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.

  2011cited by this paper
• National Healthcare Safety Network (NHSN) report, data summary for 2009, device-associated module.

  2011cited by this paper
• Ventilator-associated pneumonia in a tertiary care hospital in India: role of multi-drug resistant pathogens.

  2010cited by this paper
• Cost analysis of ventilator-associated pneumonia in Turkish medical-surgical intensive care units.

  2010cited by this paper
• Ventilator-associated pneumonia

  2009cited by this paper
• Risk factors for relapse of ventilator-associated pneumonia in trauma patients.

  2009cited by this paper
• [Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study].

  2009cited by this paper
• Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units

  2009cited by this paper
• Differences in early- and late-onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit.

  2008cited by this paper
• Optimal duration of the antimicrobial treatment of ventilator-acquired pneumonia

  2008cited by this paper
• Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis.

  2008cited by this paper
• Economic Burden of Ventilator-Associated Pneumonia Based on Total Resource Utilization

  2008cited by this paper
• Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

  2008cited by this paper
• Early predictors for infection recurrence and death in patients with ventilator‐associated pneumonia

  2007cited by this paper
• Duration of Antibiotic Therapy for Ventilator-Associated Pneumonia Caused by Non-Fermentative Gram-Negative Bacilli

  2007cited by this paper
• Excess ICU mortality attributable to ventilator-associated pneumonia: The role of early vs late onset

  2007cited by this paper
• Optimizing Antibiotic Treatment for Ventilator‐Associated Pneumonia

  2006cited by this paper
• Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia.

  2005cited by this paper
• Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria

  2005cited by this paper
• Controlling the risk of spurious findings from meta‐regression

  2004cited by this paper
• Ventilator-associated pneumonia: caveats for benchmarking

  2003cited by this paper
• Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

  2003cited by this paper
• Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center*

  2003cited by this paper
• Ventilator-associated pneumonia.

  2002cited by this paper
• Epidemiology and outcomes of ventilator-associated pneumonia in a large US database.

  2002cited by this paper
• Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

  1998cited by this paper
• The importance of quality of primary studies in producing unbiased systematic reviews.

  1996cited by this paper
• Assessing the Quality of Randomized Controlled Trials: Current Issues and Future Directions

  1996cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Duration Matters: Tailoring Antibiotic Therapy for Ventilator-Associated Pneumonia

  2026cites this paper
• Comparison of short versus long treatment duration of ESBL pneumonia in critically ill patients: a retrospective cohort study.

  2026cites this paper
• Ventilator-associated pneumonia: how long is long enough?

  2025cites this paper
• Short-course antibiotic strategies for ventilator-associated pneumonia

  2025cites this paper
• Duration of antibiotic therapy for pediatric ventilator‐associated pneumonia

  2025cites this paper
• Antibiotic Therapy Duration for Multidrug-Resistant Gram-Negative Bacterial Infections: An Evidence-Based Review

  2025cites this paper
• Prediction of the susceptible and resistant bacteria with antibiotic therapy

  2025cites this paper
• ¿Cómo podemos optimizar el abordaje diagnóstico y terapéutico de la neumonía? Recomendaciones basadas en una opinión de expertos

  2024cites this paper
• Fever and infections in surgical intensive care: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document

  2024cites this paper
• Ten golden rules for optimal antibiotic use in hospitals: based on the publication statement of the International Network Group of the World Antimicrobial Resistance

  2024cites this paper
• Evaluation of Recurrence Rates of Pseudomonas Pneumonia in Mechanically Ventilated ICU Patients Receiving ≤7 Versus >7 Days of Antibiotic Therapy

  2024cites this paper
• WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections.

  2024cites this paper
• Infectious Pulmonary Diseases.

  2024cites this paper
• Management of Ventilator-Associated Pneumonia: Guidelines.

  2024cites this paper
• Polmoniti nosocomiali acquisite sotto ventilazione meccanica

  2024cites this paper
• Duration of Antimicrobial Treatment in Adult Patients with Pneumonia: A Narrative Review

  2024cites this paper
• Therapy of Aspiration: Out-of-Hospital and In-Hospital-Acquired

  2024cites this paper
• Korean Guidelines for the Management and Antibiotic Therapy in Adult Patients with Hospital-Acquired Pneumonia

  2024cites this paper
• Guidelines for Antibiotics Prescription in Critically Ill Patients

  2024cites this paper
• How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.

  2024cites this paper
• Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial

  2023cites this paper
• Pneumopathies nosocomiales acquises sous ventilation mécanique

  2023cites this paper
• [Diagnosis and antibiotic therapy of nosocomial pneumonia in adults: from recommendations to real practice. A review].

  2023cites this paper
• Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action

  2023cites this paper
• Short-course versus prolonged-course antibiotic regimens for ventilator-associated pneumonia: A systematic review and meta-analysis of randomized controlled trials.

  2023cites this paper
• Comparison of a short versus long-course antibiotic therapy for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials

  2023cites this paper
• Management of pneumonia in the critically ill.

  2023cites this paper
• Antimicrobial Stewardship in the ICU.

  2022cites this paper
• Risk Factors and Algorithms for the Empirical Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.

  2022cites this paper
• Antibiotic indications and appropriateness in the pediatric intensive care unit: a ten-center point prevalence study.

  2022cites this paper
• The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults

  2022cites this paper
• Infectious Pulmonary Diseases.

  2022cites this paper
• The 10 commandments for the appropriate use of antibiotics in healthcare facilities

  2022cites this paper
• Practice Summary of Antimicrobial Therapy for Commonly Encountered Conditions in the Neonatal Intensive Care Unit: A Canadian Perspective

  2022cites this paper
• Nosocomial Pneumonia in the Mechanically Ventilated Patient.

  2022cites this paper
• Pneumonia in Nervous System Injuries: An Analytic Review of Literature and Recommendations

  2022cites this paper
• Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial

  2022cites this paper
• Machine learning and synthetic outcome estimation for individualised antimicrobial cessation

  2022cites this paper
• Superinfection associated with prolonged antibiotic use in non-ventilator associated hospital-acquired pneumonia

  2021cites this paper
• The Nurse’s Role in Preventing Ventilator-Associated Pneumonia

  2021cites this paper
• Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis.

  2021cites this paper
• Guidelines on Implementing Antimicrobial Stewardship Programs in Korea

  2021cites this paper
• How Antibiotics Stewardship Can Be Safely Implemented in Patients with Septic Shock?

  2021cites this paper
• Indicaciones de Uso y Modificación de Antibióticos en Paciente Graves

  2021cites this paper
• Duration of antibiotic therapy for common infections.

  2021cites this paper
• Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers

  2021cites this paper
• A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

  2021cites this paper
• Management of Pneumonia Syndromes in the Hospital: Make Pneumonia Your Best Friend.

  2020cites this paper
• Hospital-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2019 Update.

  2020cites this paper
• Safety considerations of current drug treatment strategies for nosocomial pneumonia

  2020cites this paper
• Review of Sepsis in Burn Patients in 2020

  2020cites this paper
• Duration of antimicrobial therapy for Gram-negative infections

  2020cites this paper
• Targeting the Extracellular Polysaccharide Production (EPS) by Biofilm Forming Bacteria from Orthodontic Brackets and Wires Through Antiquorum Sensing Action of Bioactive Compounds from Curcuma longa and Zingiber officinale

  2020cites this paper
• The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis

  2020cites this paper
• Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia

  2020cites this paper
• MODERN ASPECTS OF COMMUNITY-ACQUIRED PNEUMONIA

  2019cites this paper
• Recommendations and guidelines for the treatment of pneumonia in Taiwan.

  2019cites this paper
• Comparing current US and European guidelines for nosocomial pneumonia

  2019cites this paper
• Drug Prevention and Control of Ventilator-Associated Pneumonia

  2019cites this paper
• HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial

  2019cites this paper
• Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA–Specified End Points

  2019cites this paper
• COMMUNITY-ACQUIRED PNEUMONIA IN THE INTENSIVE CARE UNIT What are the Common Organisms Causing Community-Acquired Pneumonia in Intensive Care Unit Worldwide and India ?

  2019cites this paper
• Methicillin‐resistant Staphylococcus aureus in solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• Pneumonies associées aux soins de réanimation* RFE commune SFAR–SRLF

  2019cites this paper
• Guidelines for Antibiotic Prescription in Intensive Care Unit

  2019cites this paper
• An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria.

  2019cites this paper
• Adhering to the procalcitonin algorithm allows antibiotic therapy to be shortened in patients with ventilator-associated pneumonia.

  2019cites this paper
• Outpatient pulmonology in contemporary national recommendations and research

  2019cites this paper
• Pneumonie associée à la ventilation mécanique

  2018cites this paper
• Shorter Versus Longer Courses of Antibiotics for Infection in Hospitalized Patients: A Systematic Review and Meta-Analysis

  2018cites this paper
• Short- vs long-course antibiotic therapy for pneumonia: a comparison of systematic reviews and guidelines for the SIMI Choosing Wisely Campaign

  2018cites this paper
• Pneumonies associées aux soins de réanimation

  2018cites this paper
• Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance

  2018cites this paper
• FIRST JANUARY 25 , 2018 — REVIEW Shorter Versus Longer Courses of Antibiotics for Infection in Hospitalized Patients : A Systematic Review and Meta-Analysis

  2018cites this paper
• Duration of Therapy

  2018cites this paper
• Society for Translational Medicine expert consensus on the use of antibacterial drugs in thoracic surgery.

  2018cites this paper
• Major publications in the critical care pharmacotherapy literature: January–December 2016

  2018cites this paper
• Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care

  2018cites this paper
• Healthcare associated pneumonia in the intensive care unit

  2018cites this paper
• Infectious Complications in Critically Ill Liver Failure Patients

  2018cites this paper
• Comparison of methods for measuring antibiotic consumption in an intensive care unit

  2018cites this paper
• Research progress on anti-infection therapy for sepsis in children

  2018cites this paper
• Management of Ventilator-Associated Pneumonia: Guidelines.

  2018cites this paper
• Healthcare-associated Pneumonia

  2018cites this paper
• Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection

  2018cites this paper
• Vive la difference! France's new guidelines on hospital-acquired pneumonia.

  2018cites this paper
• International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

  2017cites this paper
• Antibiotic use in Departments of Internal Medicine of Lazio

  2017cites this paper
• Burden, Etiology and Control of Hospital Acquired Infections in Intensive Care Units in Vietnam

  2017cites this paper
• How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?

  2017cites this paper
• Antimicrobial Stewardship Approaches in the Intensive Care Unit.

  2017cites this paper
• [Bacterial sepsis : Diagnostics and calculated antibiotic therapy].

  2017cites this paper
• Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study

  2017cites this paper
• Letter to the editor: ‘challenges and opportunities in the treatment of ventilator-associated pneumonia’

  2017cites this paper
• Response to: ‘letter to the editor: “Challenges and opportunities in the treatment of ventilator-associated pneumonia”’

  2017cites this paper
• Duration of pneumonia therapy and the role of biomarkers

  2017cites this paper
• Hospital-acquired pneumonia in ICU.

  2017cites this paper
• Recommendations From the 2016 Guidelines for the Management of Adults With Hospital-Acquired or Ventilator-Associated Pneumonia.

  2017cites this paper
• Bacterial sepsis

  2017cites this paper
• To which extent can we decrease antibiotic duration in critically ill patients?

  2017cites this paper